Predictive testing for complex diseases using multiple genes: fact or fiction?
paper
Cited
Public
Unavailable
- Authors
- Janssens, A Cecile J W; Aulchenko, Yurii S; Elefante, Stefano; Borsboom, Gerard J J M; Steyerberg, Ewout W; van Duijn, Cornelia M
- Year
- 2006
- Journal
- Genetics in medicine : official journal of the American College of Medical Genetics
- PMID
- 16845271
- DOI
- 10.1097/01.gim.0000229689.18263.f4
PURPOSE: There is ongoing debate about whether testing low-risk genes at multiple loci will be useful in clinical care and public health. We investigated the usefulness of multiple genetic testing using simulated data. METHODS: Usefulness was evaluated by the area under the receiver-operating characteristic curve (AUC), which indicates the accuracy of genetic profiling in discriminating between future patients and nonpatients. The AUC was investigated in relation to the number of genes assumed to be involved, the risk allele frequency, the odds ratio of the risk genotypes, and to the proportion of variance explained by genetic factors as an approximation of the heritability of the disease. RESULTS: We demonstrated that a high (AUC > 0.80) to excellent discriminative accuracy (AUC > 0.95) can be obtained by simultaneously testing multiple susceptibility genes. A higher discriminative accuracy is obtained when genetic factors play a larger role in the disease, as indicated by the proportion of explained variance. The maximum discriminative accuracy of future genetic profiling can be estimated at present from the heritability and prevalence of disease. CONCLUSIONS: Genetic profiling may have the potential to identify individuals at higher risk of disease depending on the prevalence and heritability of the disease.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Evaluating genetic-based disease prediction approaches through simulation. | Shpak M et al. | — | 2026 | → |
| Explainable machine learning identifies a polygenic risk score as a key predictor of pancreatic cancer risk in the UK Biobank. | Peduzzi G et al. | — | 2025 | → |
| Polygenic risk score prediction accuracy convergence. | Henches L et al. | — | 2025 | → |
| Transfer Learning Prediction of Early Exposures and Genetic Risk Score on Adult Obesity in Two Minority Cohorts. | Chen W et al. | — | 2025 | → |
| Interplay of the Mediterranean diet and genetic hypertension risk on blood pressure in European adolescents: Findings from the HELENA study. | Pérez-Gimeno G et al. | — | 2024 | → |
| Investigation of the interaction between genetic risk score (GRS) and fatty acid quality indices on metabolic syndrome among overweight and obese women. | Rasaei N et al. | — | 2024 | → |
| Polygenic Scores and Networks of Psychopathology Symptoms. | Piazza GG et al. | — | 2024 | → |
| The role of gene-environment interaction in the formation of risk attitudes. | Groero J | — | 2024 | → |
| Genetic Risk Scores and Missing Heritability in Ovarian Cancer. | Fatapour Y et al. | — | 2023 | → |
| Overcoming attenuation bias in regressions using polygenic indices. | van Kippersluis H et al. | — | 2023 | → |
| The body mass index increases the genetic risk scores' ability to predict risk of hepatic damage in European adolescents: The HELENA study. | Seral-Cortes M et al. | — | 2023 | → |
| Development of a genetic risk score for obesity predisposition evaluation. | Damavandi N et al. | — | 2022 | → |
| Mediterranean Diet and Genetic Determinants of Obesity and Metabolic Syndrome in European Children and Adolescents. | Seral-Cortes M et al. | — | 2022 | → |
| Multivariate Analysis of Metabolomic and Nutritional Profiles among Children with Autism Spectrum Disorder. | Qureshi F et al. | — | 2022 | → |
| Research Review: A guide to computing and implementing polygenic scores in developmental research. | Allegrini AG et al. | — | 2022 | → |
| Development of a Genetic Risk Score to predict the risk of overweight and obesity in European adolescents from the HELENA study. | Seral-Cortes M et al. | — | 2021 | → |
| Genetic risk score for ovarian cancer based on chromosomal-scale length variation. | Toh C et al. | — | 2021 | → |
| Overcoming Attenuation Bias in Regressions using Polygenic Indices: A Comparison of Approaches | van Kippersluis H et al. | — | 2021 | — |
| Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction. | Galeotti AA et al. | — | 2021 | → |
| The clinical utility of polygenic risk scores for chronic lymphocytic leukemia. | Sud A et al. | — | 2021 | → |
| The importance of increasing population diversity in genetic studies of type 2 diabetes and related glycaemic traits. | Barroso I | — | 2021 | → |
| Can education be personalised using pupils' genetic data? | Morris TT et al. | — | 2020 | → |
| Combined effects of five prothrombotic genotypes and cancer on the risk of a first venous thromboembolic event. | Skille H et al. | — | 2020 | → |
| Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future Potential. | Naber SK et al. | — | 2020 | → |
| Interaction Effect of the Mediterranean Diet and an Obesity Genetic Risk Score on Adiposity and Metabolic Syndrome in Adolescents: The HELENA Study. | Seral-Cortes M et al. | — | 2020 | → |
| Sex-Specific Associations between Gut Prevotellaceae and Host Genetics on Adiposity. | Cuevas-Sierra A et al. | — | 2020 | → |
| Assessing the performance of genome-wide association studies for predicting disease risk. | Patron J et al. | — | 2019 | → |
| Complex Trait Prediction from Genome Data: Contrasting EBV in Livestock to PRS in Humans: Genomic Prediction. | Wray NR et al. | — | 2019 | → |
| Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke. The Tromsø Study. | Rinde LB et al. | — | 2019 | → |
| Genetic risk scores demonstrate the cumulative association of single nucleotide polymorphisms in gut microbiome-related genes with obesity phenotypes in preschool age children. | Wang AA et al. | — | 2019 | → |
| Models Integrating Genetic and Lifestyle Interactions on Two Adiposity Phenotypes for Personalized Prescription of Energy-Restricted Diets With Different Macronutrient Distribution. | Ramos-Lopez O et al. | — | 2019 | → |
| Imaging and Genetic Biomarkers Predicting Transition to Psychosis. | Hunter SA et al. | — | 2018 | → |
| Polygenic influences on dyslipidemias. | Dron JS et al. | — | 2018 | → |
| An Examination of Polygenic Score Risk Prediction in Individuals With First-Episode Psychosis. | Vassos E et al. | — | 2017 | → |
| Assessment of pharmacogenetic tests: presenting measures of clinical validity and potential population impact in association studies. | Tonk ECM et al. | — | 2017 | → |
| Detection of gene-environment interactions in the presence of linkage disequilibrium and noise by using genetic risk scores with internal weights from elastic net regression. | Hüls A et al. | — | 2017 | → |
| Exploring the predictive power of polygenic scores derived from genome-wide association studies: a study of 10 complex traits. | So HC et al. | — | 2017 | → |
| Methods, Tools and Current Perspectives in Proteogenomics. | Ruggles KV et al. | — | 2017 | → |
| Molecular genetics: Chaperone protein gets personal. | Siegal ML | — | 2017 | → |
| Predicting Polygenic Obesity Using Genetic Information. | Loos RJF et al. | — | 2017 | → |
| Prospective evaluation of a patented DNA test for canine hip dysplasia (CHD). | Manz E et al. | — | 2017 | → |
| Radiogenomics and radiotherapy response modeling. | El Naqa I et al. | — | 2017 | → |
| Radiogenomics: Identification of Genomic Predictors for Radiation Toxicity. | Rosenstein BS | — | 2017 | → |
| The Scope of Big Data in One Medicine: Unprecedented Opportunities and Challenges. | McCue ME et al. | — | 2017 | → |
| Utility of genetic and non-genetic risk factors in predicting coronary heart disease in Singaporean Chinese. | Chang X et al. | — | 2017 | → |
| Constructing Hypothetical Risk Data from the Area under the ROC Curve: Modelling Distributions of Polygenic Risk. | Kundu S et al. | — | 2016 | → |
| Paradoxical Relationship Between Body Mass Index and Thyroid Hormone Levels: A Study Using Mendelian Randomization. | Taylor PN et al. | — | 2016 | → |
| Prediction impact curve is a new measure integrating intervention effects in the evaluation of risk models. | Campbell W et al. | — | 2016 | → |
| Small improvement in the area under the receiver operating characteristic curve indicated small changes in predicted risks. | Martens FK et al. | — | 2016 | → |
| A predictive model for canine dilated cardiomyopathy-a meta-analysis of Doberman Pinscher data. | Simpson S et al. | — | 2015 | → |
| A Review of Emerging Technologies for the Management of Diabetes Mellitus. | Zarkogianni K et al. | — | 2015 | → |
| Evaluation of genetic risk scores for prediction of dichotomous outcomes. | Yoo W et al. | — | 2015 | → |
| Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children. | Visscher H et al. | — | 2015 | → |
| [Methodological challenges for genome-based prediction of diseases]. | Foraita R et al. | — | 2015 | → |
| Predictive or not predictive: understanding the mixed messages from the patient's DNA sequence. | Janssens AC et al. | — | 2015 | → |
| Sex-Specific Parental Effects on Offspring Lipid Levels. | Predazzi IM et al. | — | 2015 | → |
| The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention. | Kerns SL et al. | — | 2015 | → |
| Variations in inflammatory genes as molecular markers for prediction of inflammatory bowel disease occurrence. | Stankovic B et al. | — | 2015 | → |
| A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population. | Jupe ER et al. | — | 2014 | → |
| Describing the genetic architecture of epilepsy through heritability analysis. | Speed D et al. | — | 2014 | → |
| Estimating the predictive ability of genetic risk models in simulated data based on published results from genome-wide association studies. | Kundu S et al. | — | 2014 | → |
| Genetic risk score of NOS gene variants associated with myocardial infarction correlates with coronary incidence across Europe. | Carreras-Torres R et al. | — | 2014 | → |
| Genomic prediction for tuberculosis resistance in dairy cattle. | Tsairidou S et al. | — | 2014 | → |
| Jumping on the Train of Personalized Medicine: A Primer for Non- Geneticist Clinicians: Part 3. Clinical Applications in the Personalized Medicine Area. | Li A et al. | — | 2014 | → |
| Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. | Wu Y et al. | — | 2014 | → |
| Using genetic information from candidate gene and genome-wide association studies in risk prediction for alcohol dependence. | Yan J et al. | — | 2014 | → |
| Variations in predicted risks in personal genome testing for common complex diseases. | Kalf RR et al. | — | 2014 | → |
| Whole genome prediction of bladder cancer risk with the Bayesian LASSO. | de Maturana EL et al. | — | 2014 | → |
| Association of a body mass index genetic risk score with growth throughout childhood and adolescence. | Warrington NM et al. | — | 2013 | → |
| Developing genetic epidemiological models to predict risk for nasopharyngeal carcinoma in high-risk population of China. | Ruan HL et al. | — | 2013 | → |
| Genetic tests obtainable through pharmacies: the good, the bad, and the ugly. | Patrinos GP et al. | — | 2013 | → |
| Incremental value of rare genetic variants for the prediction of multifactorial diseases. | Mihaescu R et al. | — | 2013 | → |
| Modelling BMI trajectories in children for genetic association studies. | Warrington NM et al. | — | 2013 | → |
| Novel genetic analysis for case-control genome-wide association studies: quantification of power and genomic prediction accuracy. | Lee SH et al. | — | 2013 | → |
| Pitfalls of predicting complex traits from SNPs. | Wray NR et al. | — | 2013 | → |
| Power and predictive accuracy of polygenic risk scores. | Dudbridge F | — | 2013 | → |
| Predicting risk of type 2 diabetes mellitus with genetic risk models on the basis of established genome-wide association markers: a systematic review. | Bao W et al. | — | 2013 | → |
| Predictive ability of direct-to-consumer pharmacogenetic testing: when is lack of evidence really lack of evidence? | Kalf RR et al. | — | 2013 | → |
| Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies. | Chatterjee N et al. | — | 2013 | → |
| Prospects for genetic risk prediction in hypertension. | Padmanabhan S | — | 2013 | → |
| Strategies for developing prediction models from genome-wide association studies. | Wu J et al. | — | 2013 | → |
| The contribution of risk prediction models to early detection of lung cancer. | Field JK et al. | — | 2013 | → |
| The value of genetic information for diabetes risk prediction - differences according to sex, age, family history and obesity. | Mühlenbruch K et al. | — | 2013 | → |
| What if we had whole-genome sequence data for millions of individuals? | Visscher PM et al. | — | 2013 | → |
| A better coefficient of determination for genetic profile analysis. | Lee SH et al. | — | 2012 | → |
| A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study. | Thanassoulis G et al. | — | 2012 | → |
| Analytical and simulation methods for estimating the potential predictive ability of genetic profiling: a comparison of methods and results. | Kundu S et al. | — | 2012 | → |
| Assessing the incremental value of diagnostic and prognostic markers: a review and illustration. | Steyerberg EW et al. | — | 2012 | → |
| Assessment of the value of a genetic risk score in improving the estimation of coronary risk. | Lluis-Ganella C et al. | — | 2012 | → |
| Beyond the fourth wave of genome-wide obesity association studies. | Sandholt CH et al. | — | 2012 | → |
| Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. | Murea M et al. | — | 2012 | → |
| How accurate can genetic predictions be? | Dreyfuss JM et al. | — | 2012 | → |
| Investigation on cardiovascular risk prediction using genetic information. | Pu LN et al. | — | 2012 | → |
| Modelling the genetic risk in age-related macular degeneration. | Grassmann F et al. | — | 2012 | → |
| Multiple SNP testing improves risk prediction of first venous thrombosis. | de Haan HG et al. | — | 2012 | → |
| Personalized medicine and atrial fibrillation: will it ever happen? | Lubitz SA et al. | — | 2012 | → |
| Use of support vector machines for disease risk prediction in genome-wide association studies: concerns and opportunities. | Mittag F et al. | — | 2012 | → |
| AUC-RF: a new strategy for genomic profiling with random forest. | Calle ML et al. | — | 2011 | → |
| Cumulative effects of genetic risk variants on the development of common atherosclerosis. | Tsuchiya T et al. | — | 2011 | → |
| Genetic risk sum score comprised of common polygenic variation is associated with body mass index. | Peterson RE et al. | — | 2011 | → |
| Genetics of type 2 diabetes: pathophysiologic and clinical relevance. | Herder C et al. | — | 2011 | → |
| Genome-based prediction of breast cancer risk in the general population: a modeling study based on meta-analyses of genetic associations. | van Zitteren M et al. | — | 2011 | → |
| Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study. | Herder C et al. | — | 2011 | → |
| Is life law-like? | Weiss KM et al. | — | 2011 | → |
| Perspectives on the use of multiple sclerosis risk genes for prediction. | Jafari N et al. | — | 2011 | → |
| PredictABEL: an R package for the assessment of risk prediction models. | Kundu S et al. | — | 2011 | → |
| Predictive genetic testing for the identification of high-risk groups: a simulation study on the impact of predictive ability. | Mihaescu R et al. | — | 2011 | → |
| Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. | Buijsse B et al. | — | 2011 | → |
| Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. | Janssens AC et al. | — | 2011 | → |
| Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. | Janssens AC et al. | — | 2011 | → |
| Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. | Janssens AC et al. | — | 2011 | → |
| Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. | Janssens AC et al. | — | 2011 | → |
| Type 2 diabetes and obesity: genomics and the clinic. | Travers ME et al. | — | 2011 | → |
| Underestimated effect sizes in GWAS: fundamental limitations of single SNP analysis for dichotomous phenotypes. | Stringer S et al. | — | 2011 | → |
| An epidemiological perspective on the future of direct-to-consumer personal genome testing. | Janssens AC et al. | — | 2010 | → |
| Assessing the impact of a combined analysis of four common low-risk genetic variants on autism risk. | Carayol J et al. | — | 2010 | → |
| A unifying framework for evaluating the predictive power of genetic variants based on the level of heritability explained. | So HC et al. | — | 2010 | → |
| Being more realistic about the public health impact of genomic medicine. | Hall WD et al. | — | 2010 | → |
| Combining genetic markers and clinical risk factors improves the risk assessment of impaired glucose metabolism. | Ruchat SM et al. | — | 2010 | → |
| Comparison of discriminatory power and accuracy of three lung cancer risk models. | D'Amelio AM et al. | — | 2010 | → |
| Coronary heart disease risk prediction in the era of genome-wide association studies: current status and what the future holds. | Humphries SE et al. | — | 2010 | → |
| Evaluating diagnostic accuracy of genetic profiles in affected offspring families. | Carayol J et al. | — | 2010 | → |
| Genetic cardiovascular risk prediction: will we get there? | Thanassoulis G et al. | — | 2010 | → |
| Genetics of allergic disease. | Holloway JW et al. | — | 2010 | → |
| Genome-wide association studies will unlock the genetic basis of hypertension.: con side of the argument. | Kurtz TW | — | 2010 | → |
| Improvement of risk prediction by genomic profiling: reclassification measures versus the area under the receiver operating characteristic curve. | Mihaescu R et al. | — | 2010 | → |
| Multi-locus models of genetic risk of disease. | Wray NR et al. | — | 2010 | → |
| Practical issues in building risk-predicting models for complex diseases. | Kang J et al. | — | 2010 | → |
| Risk categorization for complex disorders according to genotype relative risk and precision in parameter estimates. | Goddard GH et al. | — | 2010 | → |
| The genetic interpretation of area under the ROC curve in genomic profiling. | Wray NR et al. | — | 2010 | → |
| The potential of genes and other markers to inform about risk. | Pepe MS et al. | — | 2010 | → |
| Using genetics to deliver personalized SLE therapy-a realistic prospect? | Rhodes B et al. | — | 2010 | → |
| Using genetics to predict the natural history of asthma? | Holloway JW et al. | — | 2010 | → |
| Beyond odds ratios--communicating disease risk based on genetic profiles. | Kraft P et al. | — | 2009 | → |
| Estimation of absolute risk for prostate cancer using genetic markers and family history. | Xu J et al. | — | 2009 | → |
| Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies. | Holmes MV et al. | — | 2009 | → |
| Genetic scoring analysis: a way forward in genome wide association studies? | Amin N et al. | — | 2009 | → |
| Genome-based prediction of common diseases: methodological considerations for future research. | Janssens AC et al. | — | 2009 | → |
| Genome-wide association study for type 2 diabetes: clinical applications. | Lyssenko V et al. | — | 2009 | → |
| Harnessing the information contained within genome-wide association studies to improve individual prediction of complex disease risk. | Evans DM et al. | — | 2009 | → |
| Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers. | Jakobsdottir J et al. | — | 2009 | → |
| Measures to summarize and compare the predictive capacity of markers. | Gu W et al. | — | 2009 | → |
| Obtaining the family history for common, multifactorial diseases by family physicians. A descriptive systematic review. | Plat AW et al. | — | 2009 | → |
| Predicting human height by Victorian and genomic methods. | Aulchenko YS et al. | — | 2009 | → |
| Predictive genetic testing for coronary artery disease. | Johansen CT et al. | — | 2009 | → |
| Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis. | Hoppenbrouwers IA et al. | — | 2009 | → |
| The future of genetics in psychology and psychiatry: microarrays, genome-wide association, and non-coding RNA. | Plomin R et al. | — | 2009 | → |
| Two independent prostate cancer risk-associated Loci at 11q13. | Zheng SL et al. | — | 2009 | → |
| Usefulness of genetic polymorphisms and conventional risk factors to predict coronary heart disease in patients with familial hypercholesterolemia. | van der Net JB et al. | — | 2009 | → |
| Value of genetic profiling for the prediction of coronary heart disease. | van der Net JB et al. | — | 2009 | → |
| Variations in five genes and the severity of age-related macular degeneration: results from the Muenster aging and retina study. | Farwick A et al. | — | 2009 | → |
| Accuracy of predicting the genetic risk of disease using a genome-wide approach. | Daetwyler HD et al. | — | 2008 | → |
| A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. | Janssens AC et al. | — | 2008 | → |
| Cardiovascular disease risk prediction using genetic information (gene scores): is it really informative? | Humphries SE et al. | — | 2008 | → |
| Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men. | Talmud PJ et al. | — | 2008 | → |
| Genetic testing for asthma. | Koppelman GH et al. | — | 2008 | → |
| Genome-based prediction of common diseases: advances and prospects. | Janssens AC et al. | — | 2008 | → |
| Is the time right for translation research in genomics? | Janssens AC | — | 2008 | → |
| Potential of nutrigenetics in the treatment of metabolic disorders. | Wood PA | — | 2008 | → |
| Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. | van Hoek M et al. | — | 2008 | → |
| Prediction of individual genetic risk of complex disease. | Wray NR et al. | — | 2008 | → |
| What will whole genome searches for susceptibility genes for common complex disease offer to clinical practice? | Lango H et al. | — | 2008 | → |
| Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. | Wellcome Trust Case Control Consortium | — | 2007 | → |
| Modeling the impact of genetic screening technologies on healthcare: theoretical model for asthma in children. | Gutiérrez de Mesa E et al. | — | 2007 | → |
| Prediction of individual genetic risk to disease from genome-wide association studies. | Wray NR et al. | — | 2007 | → |
| The use of meta-analysis risk estimates for candidate genes in combination to predict coronary heart disease risk. | Drenos F et al. | — | 2007 | → |